Hemostasis
Hemostasis, LLC is dedicated to developing innovative hemostatic and wound healing technologies, partnering with leading physicians to improve patient outcomes and care. They manufacture advanced medical devices and support ENT, hospital, and surgical care worldwide, emphasizing safety, efficacy, and technological advancement.
Industries
Nr. of Employees
small (1-50)
Hemostasis
Saint Paul, Minnesota, United States, North America
Products
Intranasal chitosan hemostatic dressing — extended-residence, antimicrobial option
An intranasal, chitosan-based compressed sponge dressing that expands upon hydration to occupy sinus cavities and provide hemostasis and adhesion prevention; some variants include mobile water-soluble antimicrobial agents and demonstrate >4-log microbial reduction.
Intranasal chitosan hemostatic dressing — short-residence dissolvable sponge
Chitosan-based intranasal sponge intended to separate tissues, reduce adhesions, and provide short-term hemostasis; designed to dissolve or be removed with gentle irrigation over days.
Clinic/office intranasal chitosan dressing (slender, rapid expansion)
Smaller, slender chitosan sponge platform engineered for clinic- and office-based procedures that expands rapidly on hydration and is intended to minimize bleeding and edema while preventing adhesions.
Localized drug-delivery tubular micro-sponge with delivery tool
Tubular micro-sponge device with an internal lumen and a stainless-steel delivery tool that enables surgeons to place and deliver physician-selected medicinal agents to specific nasal and sinus locations; device dissolves in 3–6 days.
Topical absorbable hemostatic powder (plant-based polysaccharide)
Implantable or topical plant-based polysaccharide powder that dehydrates blood cells on contact to accelerate clot formation and leave a stable fibrin clot; designed for moderate to severe bleeding and deliverable via applicator tips.
Topical hemostat sponge for nasal use (plant-based polysaccharide)
Patient-comfortable sponge manufactured from plant-based polysaccharides for use as an intranasal dressing to minimize bleeding, edema, and adhesions; available in platforms that dissolve over 3–14 days depending on product variant.
Intranasal chitosan hemostatic dressing — extended-residence, antimicrobial option
An intranasal, chitosan-based compressed sponge dressing that expands upon hydration to occupy sinus cavities and provide hemostasis and adhesion prevention; some variants include mobile water-soluble antimicrobial agents and demonstrate >4-log microbial reduction.
Intranasal chitosan hemostatic dressing — short-residence dissolvable sponge
Chitosan-based intranasal sponge intended to separate tissues, reduce adhesions, and provide short-term hemostasis; designed to dissolve or be removed with gentle irrigation over days.
Clinic/office intranasal chitosan dressing (slender, rapid expansion)
Smaller, slender chitosan sponge platform engineered for clinic- and office-based procedures that expands rapidly on hydration and is intended to minimize bleeding and edema while preventing adhesions.
Localized drug-delivery tubular micro-sponge with delivery tool
Tubular micro-sponge device with an internal lumen and a stainless-steel delivery tool that enables surgeons to place and deliver physician-selected medicinal agents to specific nasal and sinus locations; device dissolves in 3–6 days.
Topical absorbable hemostatic powder (plant-based polysaccharide)
Implantable or topical plant-based polysaccharide powder that dehydrates blood cells on contact to accelerate clot formation and leave a stable fibrin clot; designed for moderate to severe bleeding and deliverable via applicator tips.
Topical hemostat sponge for nasal use (plant-based polysaccharide)
Patient-comfortable sponge manufactured from plant-based polysaccharides for use as an intranasal dressing to minimize bleeding, edema, and adhesions; available in platforms that dissolve over 3–14 days depending on product variant.
Services
Contract medical device manufacturing (OEM)
Custom manufacturing of medical devices for OEM customers in an ISO 13485–certified facility, including large-capacity freeze-drying and device assembly.
Polymer research and formulation services
Polymer chemistry and formulation support from an in-house team of polymer scientists and chemists for development of hemostatic and anti-adhesion biomaterials.
Contract medical device manufacturing (OEM)
Custom manufacturing of medical devices for OEM customers in an ISO 13485–certified facility, including large-capacity freeze-drying and device assembly.
Polymer research and formulation services
Polymer chemistry and formulation support from an in-house team of polymer scientists and chemists for development of hemostatic and anti-adhesion biomaterials.
Expertise Areas
- Hemostatic biomaterials development
- ENT device design and intranasal splint technologies
- Localized drug delivery to nasal and sinus cavities
- Medical device manufacturing under ISO 13485
Key Technologies
- Chitosan-based biomaterials
- Plant-derived polysaccharide hemostats
- Hydroxyapatite-containing bone hemostat composites
- Drug-delivery micro-sponge with lumen and delivery tool